Control of Vascular Tone in the Syndromes of Bartter and Gitelman

References

• Bartter FC, Pronove P, Gill JR, et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 1962; 33: 811–828.
   PubMed Web of Science ®Google Scholar
• Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966; 79: 221–235.
   PubMedGoogle Scholar
• Bettinelli A, Bianchetti M, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman Syndromes. J Pediatr 1992; 120: 38–43.
   PubMed Web of Science ®Google Scholar
• Bartter FC. Bartter's syndrome: a disorder of vascular reactivity. Hypertension 1981; 3: 69–73.
   Google Scholar
• Simon DB, Karet FE, Hamdan JM, et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996; 13: 183–188.
   PubMed Web of Science ®Google Scholar
• Simon DB, Karet FE, Rodriguez-Soriano J, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 1996; 14: 152–156.
   PubMed Web of Science ®Google Scholar
• Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997; 17: 171–179.
   PubMed Web of Science ®Google Scholar
• Simon DB, Nelson-Williams C, Johnson Bia M, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24–30.
   PubMed Web of Science ®Google Scholar
• Padfield PL, Grekin RJ, Nicholls MG. Clinical syndromes associated with disorders of renal tubular chloride transport: excess and deficiency of a circulating factor? Med Hypotheses 1984; 14: 387–400.
   PubMedGoogle Scholar
• Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315–325.
   PubMed Web of Science ®Google Scholar
• Davis Mj, Hill MH. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 70: 387–423.
   Google Scholar
• Calo L, Davis PA, Milani M, et al. Bartter's syndrome and Gitelman's syndrome: two entities sharing the same abnormality of vascular reactivity. Clin Nephrol 1998; 50:65–67.
   PubMedGoogle Scholar
• Goodman AD, Vagnucci AH, Hartroft PM. Pathogenesis of Bartter's syndrome. N Engl J Med 1969; 281: 1435–1439.
   PubMedGoogle Scholar
• Graham RM, Bloch KD, Delaney VB, et al. Bartter's syndrome and the atrial natriuretic factor gene. Hypertension 1986; 8: 549–551.
   PubMedGoogle Scholar
• Marco-Franco JE, Morey A, Ventura C, et al. Long term evolution and growth patterns in a family with Bartter's syndrome. Clin Nephrol 1994; 42: 33–37.
   PubMedGoogle Scholar
• Zarraga Larrondo S, Vallo A, et al. Familial hypokalemia-hypomagnesemia or Gitelman's syndrome: a further case. Nephron 1992; 62: 340–344.
   PubMedGoogle Scholar
• Smilde TJ, Haverman JF, Schipper P, et al. Familial hypokalemia/hypomagnesemia and chondrocalcinosis. J Rheumatol 1994; 21: 1515–1519.
   PubMed Web of Science ®Google Scholar
• Matsumoto J, Han BK, Restrepo de Rovetto C, et al. Hypercalciuric Bartter's syndrome: resolution of nephrocalcinosis with indomethacin. Am J Roentgenol 1989; 152: 1251–1253.
   Google Scholar
• Iwata F, Hanawa Y, Takashima H. Chronic hypomagnesemia and hypokalemia due to renal wasting in siblings. Acta Pediatr Jpn 1993; 35: 252–257.
   PubMedGoogle Scholar
• Ciedel CL. Regulation of vascular smooth muscle contraction. Fed Proc 1984; 43: 2390–2398.
   PubMedGoogle Scholar
• Benjamin N, Vallance P. Local control of human peripheral vascular tone: implications for drug therapy. Clin Sci 1991; 80: 183–190.
   Google Scholar
• Somlyo AP, Somlyo AV. Flash photolysis studies of excitation-contraction coupling, regulation, and contraction in smooth muscle. Annu Rev Physiol 1990; 52: 857–874.
   PubMedGoogle Scholar
• Van Breeman C, Saida K. Cellular mechanisms regulating [Ca2+]i smooth muscle. Annu Rev Physiol 1989; 51: 315–329.
   PubMedGoogle Scholar
• Ives HE. Ion transport defects and hypertension: where is the link? Hypertension 1989; 14: 590–597.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Ushio-Fukai M, Lassegue B, et al. Angiotensin II signaling in vascular smooth muscle. New Concepts. Hypertension 1997; 29: 366–373.
   PubMed Web of Science ®Google Scholar
• Singer WD, Brown HA, Sternweis PC. Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and D. Annu Rev Biochem 1997; 66: 475–509.
   PubMedGoogle Scholar
• Somlyo AV, Bond M, Somlyo AP, et al. Inositol trisphosphate-induced calcium release and contraction in vascular smooth muscle. Proc Natl Acad Sci USA 1985; 82: 5231–5235.
   PubMed Web of Science ®Google Scholar
• Galizzi JP, Qar J, Fosset M, et al. Regulation of calcium currents in aortic smooth muscle cells by protein kinase C activators (diacylglycerol and phorbol esters) and by peptides (vasopressin and bombesin)that stimulate phosphoinositide breakdown. J Biol Chem 1987; 262: 69476950.
   Google Scholar
• Cole WC, Clement-Chomienne O, Aiello EA. Regulation of 4 aminopyridine-sensitive, delayed rectified K+ channels in vascular smooth muscle by phosphorylation. Biochem Cell Biol 1996; 74: 439–447.
   PubMed Web of Science ®Google Scholar
• Moncada S, Higgs A. The L-Arginine-nitric oxide pathway. N Engl J Med 1993; 329: 20022012.
   Google Scholar
• Boulanger MC, Vanhoutte PM. G protein and endothelium-dependent relaxations. J Vasc Res 1997; 34: 175–185.
   PubMedGoogle Scholar
• Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–666.
   PubMed Web of Science ®Google Scholar
• Marsden PA, Heng HHQ, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 1747817488.
   Google Scholar
• Clementi E. Role of nitric oxide and its intracellular signalling pathways in the control of Ca2+ homeostasis. Biochem Pharmacol 1998; 55: 713–718.
   PubMed Web of Science ®Google Scholar
• Sprang SR. G protein mechanisms: insights from structural analysis. Annu Rev Biochem 1997; 66: 639–678.
   PubMed Web of Science ®Google Scholar
• Ali N, Agrawal DK. Guanine nucleotide binding regulatory proteins: their characteristics and identification. J Pharmacol Toxicol Method 1994; 32:187–196.
   PubMedGoogle Scholar
• Birnbaumer L, Codina J, Mattera R, et al. Signal transduction by G protein. Kidney Int 1987; 32(Suppl. 23): S14-S37.
   Google Scholar
• Mironneau J, Macrez N. Specificity of Gq and G11 protein signaling in vascular myocytes. Trendo Cardiovasc Med 1998; 8:157–162.
   PubMedGoogle Scholar
• Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998; 31: 152–161.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Minieri CA, Ollerenshaw JD, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 11411148.
   Google Scholar
• Marui N, Offerman M, Swerlick R, et al. Vascular cell-adhesion molecule-1 (VCAM-1) gene-transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866–1874.
   PubMed Web of Science ®Google Scholar
• Harder DR, Lange AR, Gebremedhin D, et al. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res 1997; 34: 237–243.
   PubMed Web of Science ®Google Scholar
• Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP. Circulation 1995; 92: 3337–3349.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Calo L, Cantaro S, et al. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. Clin Sci 1987: 72: 483–488.
   Google Scholar
• Calo L, D'Angelo A, Cantaro S, et al. Intracellular calcium signalling and vascular reactivity in Bartter's syndrome. Nephron 1996; 72: 570–573.
   PubMedGoogle Scholar
• Calo L, D'Angelo A, Cantaro S, et al. Increased urinary NO2-/NO3- and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis 1996; 27: 874–879.
   Google Scholar
• Calo L, Davis PA, Milani M, et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999; 51: 12–17.
   PubMed Web of Science ®Google Scholar
• Calo L, Sartore G, Bassi A, et al. Reduced susceptibility of low-density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertension 1998; 16: 1001–1008.
   PubMed Web of Science ®Google Scholar
• Calo L, Milani M, Ceolotto G, et al. Altered cell signaling, reduced PKC, increased ecNOS and vascular hyporeactivity of Bartter's and Gitelman's syndrome. Am JHypertens 1999; 12 (n.4, part 2):53 Abstr.
   Google Scholar
• Calo, L, Felice, M, Cantaro, et al. Inhibition of furosemide-sensitive cation transport and activation of sodium-lithium exchange by endogenous circulating factor(s) in Bartter's and Gitelman's syndromes. J Hypertension 1997; 15: 1407–1413.
   PubMedGoogle Scholar
• Davis PA, Calo L. Is atherosclerosis a no NO state? Circulation 1999; 20: 2709–2712.
   Google Scholar
• Akar F, Skinner E, Klein JD, et al. Vasoconstrictors and nitrovasodilators reciprocally regulate the Na+-K+-Cl-cotransporter in rat aorta. Am J Physiol 1999; 276: C1383–1390.
   Google Scholar
• Moncada S, Palmer RMJ Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–142.
   PubMed Web of Science ®Google Scholar
• Ohara Y, Sayegh HS, Yamin JJ, et al. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension 1995; 25: 415–420.
   PubMed Web of Science ®Google Scholar
• Ceolotto G, Collin P, Clari G, et al. Protein kinase C and insulin regulation of red blood cell Na+-H+ exchange. Am J Physiol 1997; 272: C818–C826.
   Google Scholar
• Farfel Z, Bourne HR Iiri T. The expanding spectrum of G protein diseases. NEngl J Med1999; 340: 1312–1320.
   Google Scholar